On Wednesday, Shares of Intel Corporation (NASDAQ:INTC), gained 0.80% to $29.12.
Intel Corporation declared it will invest $5 million over the next five years to deepen its engineering pipeline partnership with the Georgia Institute of Technology and deploy research-driven solutions to inspire and retain women and underrepresented minorities to start and complete computer science and engineering degrees.
The Intel and Georgia Tech program, declared in conjunction with the first-ever White House Demo Day, builds on Intel’s ongoing commitment to improve diversity in the technology industry. Earlier this year, Intel declared a new aim in diversity and inclusion: to achieve full representation of underrepresented minorities and women by the year 2020 in its U.S. workforce, together with a $300 million Diversity in Technology initiative to assist build a pipeline of underrepresented engineers and computer scientists, to foster hiring and inclusion of women and underrepresented minorities at Intel, and to fund programs to support a more positive representation of women and underrepresented minorities in technology and gaming.
Intel Corporation designs, manufactures, and sells integrated digital technology platforms worldwide. It operates through PC Client Group, Data Center Group, Internet of Things Group, Mobile and Communications Group, Software and Services, and All Other segments.
Shares of Mylan N.V. (NASDAQ:MYL), declined -0.13% to $54.60, during its last trading session.
Mylan declared the U.S. launch of Esomeprazole Magnesium Delayed-release Capsules USP, 20 mg and 40 mg, which is the generic version of AstraZeneca’s Nexium®. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which is indicated for the treatment of gastroesophageal reflux disease (GERD) in adults and children ages 1 and older.
Mylan CEO Heather Bresch commented: “Mylan’s launch of Esomeprazole Magnesium Delayed-release Capsules USP represents our continued commitment to expand access to high quality medicine, and we’re happy to provide patients with another affordable treatment option. We look forward to continue delivering on our mission to set new standards in healthcare by expanding our broad portfolio of products in the U.S. and around the world.”
Esomeprazole Magnesium Delayed-Release Capsules USP, 20 mg and 40 mg, had U.S. sales of about $5.2 billion for the 12 months ending June 30, 2015, according to IMS Health.
Mylan N.V., through its auxiliaries, develops, licenses, manufactures, markets, and distributes generic, branded generic, and specialty pharmaceuticals worldwide. The company provides generic or branded generic pharmaceutical products in tablet, capsule, injectable, or transdermal patch forms, in addition to active pharmaceutical ingredients (APIs).
Finally, QEP Resources, Inc. (NYSE:QEP), ended its last trade with -1.24% loss, and closed at $13.51.
QEP Resources stated second quarter 2015 financial and operating results. The Company stated a net loss from ongoing operations of $76.3 million, or $0.43 per diluted share, for the second quarter 2015 contrast with a net loss from ongoing operations of $106.1 million, or $0.59 per diluted share, in the second quarter 2014.
Net income or loss comprises non-cash gains and losses associated with the change in the fair value of derivative instruments, gains and losses from asset sales, a non-cash pension curtailment expense and impairment charges. Not taking into account these items, the Company’s second quarter 2015 Adjusted Net Income (a non-GAAP measure) was $16.0 million, or $0.09 per diluted share, contrast with Adjusted Net Income from ongoing operations of $54.1 million, or $0.30 per diluted share, for the comparable 2014 period. The decrease in Adjusted Net Income was due primarily to significantly lower average field-level prices for crude oil, natural gas and NGL, partially offset by higher crude oil volumes, lower production taxes and higher proceeds from realized commodity derivatives.
Adjusted EBITDA (a non-GAAP measure) for the second quarter 2015 was $279.4 million, contrast with $368.2 million on a ongoing operations basis in the second quarter 2014, a 24% decrease.
QEP Resources, Inc., through its auxiliaries, operates as an exploration and production company. The company acquires, explores, develops, and produces natural gas, oil, and natural gas liquids (NGLs) primarily in the Pinedale Anticline in western Wyoming; the Williston Basin in North Dakota; the Uinta Basin in eastern Utah; the Permian Basin in western Texas; the Haynesville/Cotton Valley in northwestern Louisiana; and other proven properties in Wyoming, Utah, and Colorado.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
